Francisco Cortes-Benitez
Overview
Explore the profile of Francisco Cortes-Benitez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
56
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Del Carmen Navarrete-Mondragon R, Cortes-Benitez F, Elena Mendieta-Wejebe J, Gonzalez-Andrade M, Perez-Villanueva J
ChemMedChem
. 2024 Aug;
19(23):e202400452.
PMID: 39113101
Current treatments for type 2 diabetes (T2D) mainly rely on exercise, dietary control, and anti-diabetic drugs to enhance insulin secretion and improve insulin sensitivity. However, there is a need for...
2.
Mendoza-Jasso M, Perez-Villanueva J, Alvarado-Rodriguez J, Gonzalez-Andrade M, Cortes-Benitez F
ACS Omega
. 2024 Aug;
9(30):33224-33238.
PMID: 39100322
Protein tyrosine phosphatase 1B (PTP1B) is a promising drug target for treating type 2 diabetes (T2DM) and obesity. As a result, developing new therapies that target PTP1B is an attractive...
3.
Rodriguez-Villar K, Cortes-Benitez F, Palacios-Espinosa J, Perez-Villanueva J
Mol Inform
. 2023 Dec;
43(2):e202300206.
PMID: 38095132
Fungal infections caused by Candida are still a public health concern. Particularly, the resistance to traditional chemotherapeutic agents is a major issue that requires efforts to develop new therapies. One...
4.
Alvarez-Almazan S, Solis-Dominguez L, Duperou-Luna P, Fuerte-Gomez T, Gonzalez-Andrade M, Aranda-Barradas M, et al.
Int J Mol Sci
. 2023 Aug;
24(16).
PMID: 37628991
Type 2 diabetes (T2D) is one of the most common diseases and the 8th leading cause of death worldwide. Individuals with T2D are at risk for several health complications that...
5.
Coronell-Tovar A, Cortes-Benitez F, Gonzalez-Andrade M
J Enzyme Inhib Med Chem
. 2023 Mar;
38(1):2170369.
PMID: 36997321
In the present work, we studied the inhibitory and kinetic implications of classical PTP1B inhibitors (chlorogenic acid, ursolic acid, suramin) using three enzyme constructs (PTP1B, PTP1B, and PTP1B). The results...
6.
Poirier D, Maltais R, Rousseau J, Roy J, Phoenix S, Cortes-Benitez F, et al.
Bioorg Chem
. 2022 Sep;
129:106145.
PMID: 36174444
Prostate cancer is the most common cancer among men and the development of new therapeutic agents is needed for its treatment and/or diagnosis. 17β-hydroxysteroid dehydrogenase type 3 (17β-HSD3) is involved...
7.
Perez-Villanueva J, Matadamas-Martinez F, Yepez-Mulia L, Perez-Koldenkova V, Leyte-Lugo M, Rodriguez-Villar K, et al.
Pharmaceuticals (Basel)
. 2021 Aug;
14(8).
PMID: 34451912
Cancer is the second leading cause of death, after cardiovascular diseases. Different strategies have been developed to treat cancer; however, chemotherapy with cytotoxic agents is still the most widely used...
8.
De-la-Cruz-Martinez L, Duran-Becerra C, Gonzalez-Andrade M, Paez-Franco J, German-Acacio J, Espinosa-Chavez J, et al.
Molecules
. 2021 Jul;
26(14).
PMID: 34299651
Regulating insulin and leptin levels using a protein tyrosine phosphatase 1B (PTP1B) inhibitor is an attractive strategy to treat diabetes and obesity. Glycyrrhetinic acid (GA), a triterpenoid, may weakly inhibit...
9.
Rodriguez-Villar K, Yepez-Mulia L, Cortes-Gines M, Aguilera-Perdomo J, Quintana-Salazar E, Olascoaga Del Angel K, et al.
Molecules
. 2021 Apr;
26(8).
PMID: 33917871
Indazole is an important scaffold in medicinal chemistry. At present, the progress on synthetic methodologies has allowed the preparation of several new indazole derivatives with interesting pharmacological properties. Particularly, the...
10.
Rodriguez-Villar K, Hernandez-Campos A, Yepez-Mulia L, Sainz-Espunes T, Soria-Arteche O, Palacios-Espinosa J, et al.
Pharmaceuticals (Basel)
. 2021 Mar;
14(3).
PMID: 33668364
Candidiasis, caused by yeasts of the genus Candida, is the second cause of superficial and mucosal infections and the fourth cause of bloodstream infections. Although some antifungal drugs to treat...